APA (7th ed.) Citation

T, M., Y, Y., S, F., M, H., T, M., W, F., . . . K, F. (2026). Comparison of prostate-specific antigen kinetics between androgen receptor signaling inhibitor doublet therapy and androgen receptor signaling inhibitor with docetaxel triplet therapy in patients with metastatic castration-sensitive prostate cancer. Urologic oncology, 44(3), 110968. https://doi.org/10.1016/j.urolonc.2025.12.004

Chicago Style (17th ed.) Citation

T, Morita, et al. "Comparison of Prostate-specific Antigen Kinetics Between Androgen Receptor Signaling Inhibitor Doublet Therapy and Androgen Receptor Signaling Inhibitor with Docetaxel Triplet Therapy in Patients with Metastatic Castration-sensitive Prostate Cancer." Urologic Oncology 44, no. 3 (2026): 110968. https://doi.org/10.1016/j.urolonc.2025.12.004.

MLA (9th ed.) Citation

T, Morita, et al. "Comparison of Prostate-specific Antigen Kinetics Between Androgen Receptor Signaling Inhibitor Doublet Therapy and Androgen Receptor Signaling Inhibitor with Docetaxel Triplet Therapy in Patients with Metastatic Castration-sensitive Prostate Cancer." Urologic Oncology, vol. 44, no. 3, 2026, p. 110968, https://doi.org/10.1016/j.urolonc.2025.12.004.